Skip to search formSkip to main contentSkip to account menu

TZD 18

Known as: TZD-18, TZD18 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Dual PPARα/γ ligand TZD18 improves myocardial metabolic remodeling after myocardial infarction in rats.
OBJECTIVE To investigate the changes in myocardial energy metabolism and the effect of peroxisome proliferator-activated receptor… 
2016
2016
Possible mechanism of PPARα / γ activator TZD 18 in gastric cancer
The incidence and mortality rate of gastric cancer increased year by year. Current chemotherapy drug plays a key role in anti… 
2008
2008
Mit oralen Antidiabetika behandelte Patienten mit Typ-2-Diabetes nehmen signifikant an Gewicht ab, wenn bei Einleitung einer Therapie mit Insulindetemir Sulfonylharnstoffe oder Thiazolidindione…
Fragestellung: Ziel der vorliegenden Untersuchung war es, Daten zum Gewichtsverlauf von neu auf Insulindetemir (IDet… 
2006
2006
Tip 2 diyabet tedavisinde insülin duyarlılık arttırıcı ilaçların yeri
Hastanin yasam kalitesini bozmasinin yanisira, kardiyovaskuler komplikasyonlar nedeniylemortaliteyle sonuclanan ve tum dunyada… 
2004
2004
A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR / AGONIST . II . IDENTIFICATION OF METABOLITES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
The in vitro metabolism of MK-0767 [( )-5-[(2,4-dioxothiazolidin-5-yl) methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl…